Sign in to view content

Phase 3 Randomized, Double-Masked Studies of Brolucizumab Versus Aflibercept in nAMD: Expanded Primary and Secondary Outcomes From HAWK/HARRIER

Arshad M. Khanani, MD, MA, FASRS

Video
Published 2018

Related

Direct-to-Consumer Marketing by U.S. Cell Therapy Clinics for Retinal Conditions
Ajay E Kuriyan, MD, MS
Annual Meeting Talks
2018
Outcomes of Anti-VEGF Treatment for CNV in Fellow Eyes of Previously Treated Patients with Wet AMD
Tarek S. Hassan, MD, FASRS
Updates from the Field
2019
Comparative Study of Inverted ILM Flap and PRP as an Adjunct in Large Macular Holes
Naresh Babu Kannan, MS, FNB(V R),MBA (H R),FASRS,.
Annual Meeting Talks
2018

Category: Age-Related Macular Degeneration

See more